NASDAQ:ANNX Annexon (ANNX) News Today $2.98 -0.02 (-0.67%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$2.92▼$3.1650-Day Range$2.10▼$6.3752-Week Range$2.07▼$7.65Volume1.38 million shsAverage Volume1.54 million shsMarket Capitalization$158.18 millionP/E RatioN/ADividend YieldN/APrice Target$14.71 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANNX Media Mentions By Week ANNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.270.55▲Average Medical News Sentiment ANNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼42▲ANNX Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBain Capital Life Sciences Inv Buys 300,000 Shares of Annexon, Inc. (NASDAQ:ANNX) Stockamericanbankingnews.com - June 1 at 4:42 AMAnnexon, Inc. (NASDAQ:ANNX) Sees Significant Decrease in Short Interestamericanbankingnews.com - May 29 at 8:14 AMAnnexon (NASDAQ:ANNX) Cut to "Neutral" at JPMorgan Chase & Co.americanbankingnews.com - May 28 at 5:20 AMAnnexon (NASDAQ:ANNX) Downgraded to "Neutral" at Bank of Americaamericanbankingnews.com - May 27 at 5:39 AMAnnexon (NASDAQ:ANNX) Price Target Cut to $7.00 by Analysts at BTIG Researchamericanbankingnews.com - May 27 at 2:52 AMTraders Buy High Volume of Put Options on Annexon (NASDAQ:ANNX)americanbankingnews.com - May 27 at 2:02 AMK2 Principal Fund L.P. Increases Stock Position in Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - May 26 at 2:58 PMB of A Securities Downgrades Annexon (ANNX)msn.com - May 26 at 2:49 PMAnnexon (NASDAQ:ANNX) Rating Lowered to Neutral at Bank of Americamarketbeat.com - May 26 at 7:28 AMAnnexon (NASDAQ:ANNX) Downgraded to Neutral at JPMorgan Chase & Co.americanbankingnews.com - May 26 at 6:30 AMACCD, GSIT and ANNX are among after hour moversseekingalpha.com - May 25 at 11:47 PMAnalyst Expectations for Annexon's Futuremarkets.businessinsider.com - May 25 at 6:45 PMWhy Annexon (ANNX) Stock Is Getting Hammeredmsn.com - May 25 at 6:45 PMBTIG Maintains Annexon (ANNX) Buy Recommendationmsn.com - May 25 at 1:45 PMAnnexon's Eye Disease Drug Reports Mixed Trial Results, Will Focus On Planned Late-Stage Studyfinance.yahoo.com - May 25 at 1:45 PMWhy Shares of Annexon Are Plummeting Thursdayfinance.yahoo.com - May 25 at 1:45 PMAnnexon, Inc. (NASDAQ:ANNX) Receives Average Recommendation of "Moderate Buy" from Analystsamericanbankingnews.com - May 25 at 8:48 AMBTIG Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)markets.businessinsider.com - May 25 at 8:44 AMAnnexon Drops after Geographic Atrophy Candidate Disappointsmsn.com - May 25 at 8:44 AMAnnexon geographic atrophy candidate fails in phase 2; down 20%seekingalpha.com - May 25 at 1:42 AMAnalysts Issue Forecasts for Annexon, Inc.'s FY2023 Earnings (NASDAQ:ANNX)americanbankingnews.com - May 17 at 7:58 AMAnnexon's (ANNX) Overweight Rating Reiterated at Cantor Fitzgeraldamericanbankingnews.com - May 17 at 6:20 AMQ2 2023 Earnings Estimate for Annexon, Inc. (NASDAQ:ANNX) Issued By HC Wainwrightmarketbeat.com - May 12 at 8:52 AMAnnexon (NASDAQ:ANNX) Releases Earnings Results, Hits Estimatesamericanbankingnews.com - May 10 at 7:18 AMAnnexon Biosciences: Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progressfinanznachrichten.de - May 9 at 7:16 PMAnnexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progressmarketwatch.com - May 9 at 7:16 PMAnalyst Ratings for Annexonmarkets.businessinsider.com - May 9 at 7:16 PMAnnexon Biosciences (ANNX) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - May 9 at 7:16 PMNeedham Reiterates Annexon (ANNX) Buy Recommendationmsn.com - May 9 at 7:16 PMHC Wainwright & Co. Reiterates Annexon (ANNX) Buy Recommendationmsn.com - May 9 at 7:16 PMBank of Montreal Can Invests $365,000 in Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - May 4 at 4:48 AMAnnexon (NASDAQ:ANNX) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - April 23 at 2:38 AMAnnexon, Inc. (NASDAQ:ANNX) Short Interest Updateamericanbankingnews.com - April 20 at 2:44 AMAnnexon, Inc. (NASDAQ:ANNX) Sees Significant Increase in Short Interestmarketbeat.com - April 18 at 2:39 AMAnnexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 11 at 9:24 AMOne Annexon, Inc. (NASDAQ:ANNX) insider upped their stake by 59% in the previous yearfinance.yahoo.com - March 25 at 10:29 AMCantor Fitzgerald Brokers Boost Earnings Estimates for Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - March 17 at 6:36 AMAnnexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestonesfinance.yahoo.com - March 6 at 8:46 AMAnnexon, Inc. (NASDAQ:ANNX) Short Interest Up 5.3% in Februarymarketbeat.com - March 6 at 3:32 AMAnnexon, Inc. (NASDAQ:ANNX) Shares Acquired by Bain Capital Life Sciences Investors LLCmarketbeat.com - February 28 at 11:40 AMAnnexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conferencefinance.yahoo.com - February 27 at 9:08 AMPictet Asset Management SA Boosts Stock Position in Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - February 22 at 6:00 AMMassachusetts Financial Services Co. MA Raises Stock Holdings in Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - February 15 at 5:15 AMAnnexon, Inc.'s (NASDAQ:ANNX) Intrinsic Value Is Potentially 27% Above Its Share Pricefinance.yahoo.com - February 12 at 8:20 AMJefferies Financial Group Equities Analysts Lower Earnings Estimates for Annexon, Inc. (NASDAQ:ANNX)marketbeat.com - January 13 at 7:43 AMAnnexon, Inc. (NASDAQ:ANNX) Forecasted to Post FY2027 Earnings of ($0.63) Per Sharemarketbeat.com - January 12 at 8:54 AMAnnexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchisesfinance.yahoo.com - January 8 at 10:07 AMAnnexon Appoints Industry Veteran, Dr. Rick Artis, as Chief Scientific Officer to Support the Advancement and Expansion of Complement-focused Portfoliofinance.yahoo.com - January 6 at 10:48 AMAnnexon to Present at 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 4 at 10:36 AMWall Street Analysts Think Annexon, Inc. (ANNX) Could Surge 241%: Read This Before Placing a Betfinance.yahoo.com - December 1 at 6:57 PM Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LIAN News Today SBTX News Today FHTX News Today SVRA News Today INZY News Today KPTI News Today RPHM News Today NGM News Today GBIO News Today ALXO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ANNX) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.